About this trial
This study aims to assess the effect of age of the male partner and the reproductive ability of sperm prepared via sperm selection devices (Zymot) compared to routine embryologist selected sperm after density gradient centrifugation (DGC) preparation for intracytoplasmic sperm injection (ICSI) in patients undergoing in vitro fertilization treatment (IVF) of their infertility.
Eligibility criteria
Qualifiers
Undergoing first IVF cycle
Electing single embryo transfer
Electing PGT-A of their embryos
Female partners age <42 years old at start of VOR cycle, but >18 years old.
Disqualifiers
Contraindication to IVF
Clinical indication for preimplantation genetic testing (i.e., screening for single gene disorder, chromosomal translocation, or any other disorders requiring a more detailed embryo genetic analysis)
Male partner with azoospermia or oligozoospermia (<500,000 total motile spermatozoa on the most recent semen analysis within one year of enrollment)
Planned for previously cryopreserved sperm to be used for ICSI
Trial design
Treatments tested in this trial
- Microfluidic sperm separation device
- Density grade centrifugation